0.00Open0.00Pre Close0 Volume0 Open Interest1040.00Strike Price0.00Turnover8685.89%IV-35.93%PremiumJan 3, 2025Expiry Date274.90Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9904Delta0.0003Gamma--Leverage Ratio-1542.5164Theta0.0000Rho0.00Eff Leverage0.0003Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet